Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Non-cash Items: 2020-2023

  • Relay Therapeutics' Non-cash Items fell 45.43% to $18.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $18.9 million, marking a year-over-year decrease of 45.43%. This contributed to the annual value of $7.9 million for FY2024, which is 18.13% up from last year.
  • Per Relay Therapeutics' latest filing, its Non-cash Items stood at $18.9 million for Q4 2023, which was down 45.43% from $34.6 million recorded in Q4 2022.
  • Relay Therapeutics' Non-cash Items' 5-year high stood at $196.6 million during Q4 2020, with a 5-year trough of $18.9 million in Q4 2023.
  • Moreover, its 3-year median value for Non-cash Items was $34.6 million (2022), whereas its average is $54.9 million.
  • Data for Relay Therapeutics' Non-cash Items shows a maximum YoY crashed of 68.79% (in 2022) over the last 5 years.
  • Quarterly analysis of 4 years shows Relay Therapeutics' Non-cash Items stood at $196.6 million in 2020, then tumbled by 43.54% to $111.0 million in 2021, then tumbled by 68.79% to $34.6 million in 2022, then crashed by 45.43% to $18.9 million in 2023.
  • Its Non-cash Items was $18.9 million in Q4 2023, compared to $34.6 million in Q4 2022 and $111.0 million in Q4 2021.